U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
147571147571Safety Study of 20,000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild AsthmaTerminatedNo Results AvailableMild Allergic Rhinitis|Mild Allergic Rhinitis With Mild AsthmaBiological: Clinical Center Reference Endotoxinhttps://ClinicalTrials.gov/show/NCT00630461
147572147572Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)WithdrawnNo Results AvailableVon Willebrand Diseasehttps://ClinicalTrials.gov/show/NCT00630448
147573147573Study Comparing 3 New Formulations of Premarin® 0.625 mg/MPA 2.5 mg With a Reference FormulationCompletedNo Results AvailableMenopauseDrug: Premarin®/MPA formulation A|Drug: Premarin®/MPA formulation B|Drug: Premarin®/MPA formulation C|Drug: Premarin®/MPA currently marketed producthttps://ClinicalTrials.gov/show/NCT00630435
147574147574Functional Abilities in Rett SyndromeCompletedNo Results AvailableRett Syndromehttps://ClinicalTrials.gov/show/NCT00630422
147575147575Phase II Clinical Trial of Gemcitabine and Doxil® for Metastatic Renal Cell CarcinomaCompletedNo Results AvailableMetastatic Renal Cell CarcinomaDrug: Gemcitabine|Drug: Doxilhttps://ClinicalTrials.gov/show/NCT00630409
147576147576Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic StrokeCompletedHas ResultsStroke, AcuteDrug: Minocyclinehttps://ClinicalTrials.gov/show/NCT00630396
147577147577Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.WithdrawnNo Results AvailableMultiple SclerosisBiological: Live Hookworm Larvae|Other: Histaminehttps://ClinicalTrials.gov/show/NCT00630383
147578147578A Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress SyndromeTerminatedNo Results AvailablePost Prandial Distress SyndromeDrug: Placebo|Drug: 20 mg ATI 7505|Drug: 40 mg ATI 7505|Drug: 80 mg ATI 7505https://ClinicalTrials.gov/show/NCT00630370
147579147579Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial EpilepsyCompletedNo Results AvailableEpilepsyDrug: Levetiracetam (Keppra)https://ClinicalTrials.gov/show/NCT00630357
147580147580RAD001 and Bicalutamide for Androgen Independent Prostate CancerTerminatedHas ResultsProstate CancerDrug: RAD001|Drug: Bicalutamidehttps://ClinicalTrials.gov/show/NCT00630344
147581147581Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult SubjectsCompletedHas ResultsInfluenzaBiological: Cell culture-derived influenza vaccine|Biological: Egg-derived influenza virus vaccine|Biological: Placebohttps://ClinicalTrials.gov/show/NCT00630331
147582147582Testing New Method of Analyzing MR ImagesTerminatedNo Results AvailableBreast AbnormalitiesDevice: MRIhttps://ClinicalTrials.gov/show/NCT00630318
147583147583Endothelial Bleb Response With Toric LensesCompletedNo Results AvailableVision CorrectionDevice: toric contact lenses|Device: toric contact lenses|Device: toric contact lenseshttps://ClinicalTrials.gov/show/NCT00630305
147584147584Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast TumorsTerminatedHas ResultsBreast CancerOther: Magnetic Resonance Angiography (MRA) of the Breasthttps://ClinicalTrials.gov/show/NCT00630292
147585147585Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic PancreatitisTerminatedNo Results AvailablePancreatic Exocrine Insufficiency Due to Chronic PancreatitisDrug: Placebo|Drug: Recombinant Microbial Lipase SLV339|Drug: Recombinant Microbial Lipase SLV339|Drug: Recombinant Microbial Lipase SLV339https://ClinicalTrials.gov/show/NCT00630279
147586147586Confirmation Trial of the Acorn CorCap Cardiac Support Device (CSD) at the Same Time as Mitral Valve RepairRecruitingNo Results AvailableHeart FailureDevice: CorCap CSDhttps://ClinicalTrials.gov/show/NCT00630266
147587147587Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi AnemiaRecruitingNo Results AvailableFanconi AnemiaBiological: anti-thymocyte globulin|Drug: cyclophosphamide|Drug: fludarabine phosphate|Procedure: hematopoietic stem cell transplantation|Drug: methylprednisolone|Drug: filgrastim|Drug: cyclosporine|Drug: Mycophenolate Mofetilhttps://ClinicalTrials.gov/show/NCT00630253
147588147588Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial ChemoembolizationCompletedNo Results AvailableHepatocellular Carcinomahttps://ClinicalTrials.gov/show/NCT00630240
147589147589Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous StudyCompletedNo Results AvailableHomogeneous EmphysemaBiological: Biologic Lung Volume Reductionhttps://ClinicalTrials.gov/show/NCT00630227
147590147590Prevention of Hypocalcemia in Patients Undergoing Total Thyroidectomy Plus Central Neck DissectionCompletedNo Results AvailableHypocalcemiaDietary Supplement: Oral calcium plus vitamin D|Dietary Supplement: Oral calcium alonehttps://ClinicalTrials.gov/show/NCT00630214
147591147591Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid DependenceCompletedNo Results AvailableOpioid DependenceDrug: Probuphine (buprenorphine implant)https://ClinicalTrials.gov/show/NCT00630201
147592147592Shared Decision Making for Prostate Cancer Screening: a Practice-Based Randomized Controlled TrialCompletedNo Results AvailableProstatic NeoplasmsOther: You Decide|Other: Reducing Your Risks in the Crashhttps://ClinicalTrials.gov/show/NCT00630188
147593147593Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary InsomniaCompletedNo Results AvailableSleep Initiation and Maintenance DisordersDrug: zolpidem-MR (modified release)|Drug: zolpidem (SL800750)|Drug: placebohttps://ClinicalTrials.gov/show/NCT00630175
147594147594Intestinal Protozoal Infections and Sexual Transmitted Diseases Among Targeted CohortsCompletedNo Results AvailableHIV Infections|Protozoan InfectionsGenetic: amoebahttps://ClinicalTrials.gov/show/NCT00630162
147595147595Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based ChemotherapyCompletedNo Results AvailableNasopharyngeal NeoplasmsDrug: Pemetrexed (Alimta)https://ClinicalTrials.gov/show/NCT00630149
147596147596Effectiveness of the Consent ProcessCompletedNo Results AvailableParental ConsentBehavioral: interviewhttps://ClinicalTrials.gov/show/NCT00630136
147597147597Effect of Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation(TMS) on Brain Derived Neurotrophic Factor (BDNF) in Depressed Patients.Active, not recruitingNo Results AvailableDepressionhttps://ClinicalTrials.gov/show/NCT00630123
147598147598Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung CancerCompletedNo Results AvailableCancerDrug: docetaxel|Drug: NPI-2358 + docetaxelhttps://ClinicalTrials.gov/show/NCT00630110
147599147599A Dose Ranging Study of Modafinil for Methamphetamine DependenceActive, not recruitingNo Results AvailableSubstance Dependence|Amphetamine DependenceDrug: modafinilhttps://ClinicalTrials.gov/show/NCT00630097
147600147600Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular CarcinomaCompletedNo Results AvailableChronic Hepatitis C|NeoplasmsDrug: pegylated interferon alpha 2a and plus ribavirin|Drug: pegylated interferon alpha 2a and plus ribavirinhttps://ClinicalTrials.gov/show/NCT00630084

* Görseller ve İçerik tekif hakkına sahip olabilir